Biblio

Export 1008 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R., Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES)., J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES)., J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES)., J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C., Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals., J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
P. Siddarth, Rahi, B., Emerson, N. D., Burggren, A. C., Miller, K. J., Bookheimer, S., Lavretsky, H., Dobkin, B., Small, G., and Merrill, D. A., Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints., J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
P. Siddarth, Rahi, B., Emerson, N. D., Burggren, A. C., Miller, K. J., Bookheimer, S., Lavretsky, H., Dobkin, B., Small, G., and Merrill, D. A., Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints., J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., Plasma Biomarkers of Alzheimer's Disease in African Americans., J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition., J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition., J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
C. S. Atwood and Perry, G., Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
J. Andersson, Sundström, A., Nordin, M., Segersson, D., Forsberg, B., Adolfsson, R., and Oudin, A., PM2.5 and Dementia in a Low Exposure Setting: The Influence of Odor Identification Ability and APOE., J Alzheimers Dis, vol. 92, no. 2, pp. 679-689, 2023.
J. Lakey-Beitia, Burillo, A. M., La Penna, G., Hegde, M. L., and Rao, K. S., Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S335-S357, 2021.
J. Lakey-Beitia, Burillo, A. M., La Penna, G., Hegde, M. L., and Rao, K. S., Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S335-S357, 2021.
F. He, Luo, H., Yin, L., Roosaar, A., Axéll, T., Zhao, H., and Ye, W., Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up., J Alzheimers Dis, vol. 92, no. 1, pp. 171-181, 2023.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.

Pages